Vicarious Surgical (RBOT) Cash & Current Investments (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Cash & Current Investments came in at $9.8 million in Q4 2025, down 80.06% year-on-year from $49.1 million in Q4 2024, and down 58.62% on a QoQ basis from $23.7 million in Q3 2025.
Vicarious Surgical (RBOT) Cash & Current Investments (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Cash & Current Investments data on file, last reported at $9.8 million in Q4 2025.
- On a quarterly basis, Cash & Current Investments fell 80.06% year-over-year to $9.8 million in Q4 2025; TTM through Dec 2025 was $9.8 million, a 80.06% decrease from a year earlier, with the FY2025 full-year figure at $9.8 million, down 80.06% from the prior year.
- Cash & Current Investments for Q4 2025 stood at $9.8 million, down from $23.7 million in the prior quarter.
- Over the last five years, Cash & Current Investments for RBOT reached as high as $185.0 million in Q3 2021 and fell as low as $1.0 million in Q1 2021.
- Historically, Cash & Current Investments has averaged $87.0 million across 5 years, with a median of $72.7 million in 2024.
- Across the five-year window, Cash & Current Investments soared 15173.98% in 2022 and slumped 80.06% in 2025, its largest moves.
- Year by year, Cash & Current Investments stood at $173.5 million in 2021, then sank by 33.02% to $116.2 million in 2022, then grew by 5.16% to $122.2 million in 2023, then tumbled by 59.82% to $49.1 million in 2024, then slumped by 80.06% to $9.8 million in 2025.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $9.8 million in Q4 2025, $23.7 million in Q3 2025, and $24.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Vicarious Surgical | 625,212.51 | -9.17 Mn | - | 9.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.79 Mn |
| Sep 30, 2025 | 23.66 Mn |
| Jun 30, 2025 | 23.96 Mn |
| Mar 31, 2025 | 72.13 Mn |
| Dec 31, 2024 | 49.10 Mn |
| Sep 30, 2024 | 60.86 Mn |
| Jun 30, 2024 | 73.23 Mn |
| Mar 31, 2024 | 123.64 Mn |
| Dec 31, 2023 | 122.20 Mn |
| Sep 30, 2023 | 169.30 Mn |
| Jun 30, 2023 | 50.06 Mn |
| Mar 31, 2023 | 54.18 Mn |
| Dec 31, 2022 | 116.21 Mn |
| Sep 30, 2022 | 126.80 Mn |
| Jun 30, 2022 | 141.32 Mn |
| Mar 31, 2022 | 157.01 Mn |
| Dec 31, 2021 | 173.51 Mn |
| Sep 30, 2021 | 185.05 Mn |
| Jun 30, 2021 | 7.71 Mn |
| Mar 31, 2021 | 1.03 Mn |